Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies.

Histopathology - 1 Nov 1994

Skov B G, Lauritzen A F, Hirsch F R, Skov T, Nielsen H W

Abstract excerpt

A panel of antibodies against keratins, epithelial membrane antigen (EMA), epithelial antigen (Ber-EP4), carcinoembryonic antigen (CEA), tumour-associated glycoprotein (B72.3), vimentin and LeuM1 was applied to sections of adenocarcinoma of the lung and malignant mesothelioma in a randomized design. The proportion of stained tumour cells within each section was estimated independently in five categories by three...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antibodies, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diagnosis, Differential

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Phenotype

Share to Predictive Value of Tests

Share to Reproducibility of Results

Source

Identifiers

PMID: 7868083
DOI: 10.1111/j.1365-2559.1994.tb00004.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies.PMID 7868083Read ↗

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.Semantic proximity Read ↗

Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases.Semantic proximity Read ↗

Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.Semantic proximity Read ↗

E-cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthlessSemantic proximity Read ↗

Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification.Semantic proximity Read ↗

The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non-small cell lung cancer: An institutional experience.Semantic proximity Read ↗

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.Semantic proximity Read ↗

Validation of a Gene-Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive SeriesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.